Literature DB >> 7480160

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms.

J A Beavo1.   

Abstract

In the last few years there has been a veritable explosion of knowledge about cyclic nucleotide phosphodiesterases. In particular, the accumulating data showing that there are a large number of different phosphodiesterase isozymes have triggered an equally large increase in interest about these enzymes. At least seven different gene families of cyclic nucleotide phosphodiesterase are currently known to exist in mammalian tissues. Most families contain several distinct genes, and many of these genes are expressed in different tissues as functionally unique alternative splice variants. This article reviews many of the more important aspects about the structure, cellular localization, and regulation of each family of phosphodiesterases. Particular emphasis is placed on new information obtained in the last few years about how differential expression and regulation of individual phosphodiesterase isozymes relate to their function(s) in the body. A substantial discussion of the currently accepted nomenclature is also included. Finally, a brief discussion is included about how the differences among distinct phosphodiesterase isozymes are beginning to be used as the basis for developing therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480160     DOI: 10.1152/physrev.1995.75.4.725

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  296 in total

1.  mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module.

Authors:  K L Dodge; S Khouangsathiene; M S Kapiloff; R Mouton; E V Hill; M D Houslay; L K Langeberg; J D Scott
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

2.  Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses.

Authors:  T C Bellamy; J Wood; D A Goodwin; J Garthwaite
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D.

Authors:  G Hansen; S Jin; D T Umetsu; M Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

4.  Cloning and characterization of PDE7B, a cAMP-specific phosphodiesterase.

Authors:  J M Hetman; S H Soderling; N A Glavas; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

5.  Identification of a novel isoform of the cyclic-nucleotide phosphodiesterase PDE3A expressed in vascular smooth-muscle myocytes.

Authors:  Y H Choi; D Ekholm; J Krall; F Ahmad; E Degerman; V C Manganiello; M A Movsesian
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

Review 6.  The receptor-like properties of nitric oxide-activated soluble guanylyl cyclase in intact cells.

Authors:  Tomas C Bellamy; John Garthwaite
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

7.  KMUP-1 relaxes rabbit corpus cavernosum smooth muscle in vitro and in vivo: involvement of cyclic GMP and K(+) channels.

Authors:  Rong-Jyh Lin; Bin-Nan Wu; Yi-Ching Lo; Kuo-Pyng Shen; Young-Tso Lin; Chun-Hsiung Huang; Ing-Jun Chen
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

8.  A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell.

Authors:  T C Rich; K A Fagan; T E Tse; J Schaack; D M Cooper; J W Karpen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

9.  T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3.

Authors:  N A Glavas; C Ostenson; J B Schaefer; V Vasta; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

10.  An investigation of the effects of zaprinast, a PDE inhibitor, on the nitrergic control of the urethra in anaesthetized female rats.

Authors:  Alexandra Wibberley; Philip A Nunn; Alasdair M Naylor; Andrew G Ramage
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.